| J9271 | Injection, pembrolizumab, 1 mg | 10,800 | $40 | $464.4K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 5,760 | $40 | $218.9K |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 1,320 | $30 | $44.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 400 | $90 | $36.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 360 | $100 | $36.1K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 14,720 | $1 | $29.4K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 140 | $130 | $18.3K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 220 | $80 | $16.4K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 360 | $20 | $8.2K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 140 | $50 | $6.7K |